GenSight Biologics
SIGHT.PA
#9645
Rank
ยฃ28.78 M
Marketcap
ยฃ0.22
Share price
-4.78%
Change (1 day)
-36.46%
Change (1 year)

Revenue for GenSight Biologics (SIGHT.PA)

Revenue in 2024: ยฃ1.17 Million

According to GenSight Biologics's latest financial reports the company's current revenue (TTM ) is ยฃ1.17 Million. In 2024 the company made a revenue of ยฃ1.17 Million an increase over the revenue in the year 2023 that were of ยฃ1.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GenSight Biologics from 2013 to 2024

Annual revenue

Year Revenue Change
2024ยฃ1.17 M11.45%
2023ยฃ1.05 M-49.43%
2022ยฃ2.07 M-53.65%
2021ยฃ4.48 M10.56%
2020ยฃ4.05 M589.22%
2019ยฃ0.58 M
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A